|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.45 EUR | -9.11% |
|
+3.89% | +81.74% |
NewAmsterdam Pharma Company N.V. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 97.5 million. Net loss was EUR 78.05 million compared to EUR 28.6 million a year ago.
Basic loss per share from continuing operations was EUR 0.96 compared to EUR 2.53 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +81.74% | 1.8B | |
| +15.58% | 121B | |
| +16.60% | 110B | |
| +17.73% | 25.98B | |
| -24.33% | 19.27B | |
| -19.35% | 15.99B | |
| -17.95% | 15.66B | |
| -48.32% | 14.5B | |
| +58.78% | 14.47B | |
| +4.91% | 13.91B |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION 
